CRH drops $8.5B on Arcosa, betting big on infrastructure. High valuation, but potential for growth.
BP med recall: 11K+ bottles pulled for potential ineffectiveness. Risk to patients, impact on pharma firms unclear.
Recall hits BP meds: 11k+ bottles ineffective. FDA flags manufacturing issues, impacting healthcare sector.
Dow climbs as SpaceX dips. S&P, Nasdaq slide amid Iran peace talks. Watch valuations!
FDA recalls BP meds: 11k+ bottles ineffective. Risk to patients, potential impact on pharma sector.
Dow hits record high on oil price drop; S&P & Nasdaq dip. Treasury OKs Iran oil sales.
CRH buys Arcosa for $8.5B, betting on US infra boom. Investors eye construction sector gains.
Sponsored
Must Read